GL1X · GenesisL1 explorer

MolNFT v1 · #150078 · protein

Human impase with mn

6GJ0 · Inositol monophosphatase 1: “Human impase with mn”. X-ray diffraction, 1 ligand (MN), 5 pockets (best druggability 0.77). MolNFT v1 #150078 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6GJ0
Type
protein
Length
549 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Inositol monophosphatase 1
EC
3.1.3.25, 3.1.3.94
UniProt
P29218
Ligands
MN
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 37% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInositol monophosphatase 1 (EC 3.1.3.25, 3.1.3.94)protein27437% helix, 24% strandP29218
BInositol monophosphatase 1 (EC 3.1.3.25, 3.1.3.94)protein27536% helix, 25% strandP29218

Ligands and binding sites

  • MN · Manganese (II) ion · metal · 6 copies · chains A, B
  • GOL · Glycerol · additive · 6 copies · chains A, B
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14040.770.8647MN, GOL, MES
23900.760.8652MN, GOL, MES
34740.620.7557GOL
41030.360.7417empty
5770.340.7514empty

Interfaces

1 interface between chains.

  • A–B · 1661 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 6GJ0 · Human IMPase with Mn · the same entry in another collection · chain A against A, TM-score 1.00
  • P29218 · AlphaFold monomer V2.0 prediction for inositol monophosphatase 1 (P29218) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.